European shares slide as EU stimulus fails to impress [Reuters]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Reuters
European shares slide as EU stimulus fails to impress (Reuters) - European stock markets fell on Friday with investors disappointed by the lack of details in a trillion-euro emergency fund agreed by the bloc’s leaders as evidence grew of the global damage wrought by the coronavirus crisis. After weeks of squabbling, EU leaders approved an immediate rescue package of about 500 billion euros but left the divisive details of a bigger fund until the summer, sending the pan-European STOXX 600 index down 1.2% in early trading. The slide put the benchmark index on course to end a two-week winning streak, adding to a selloff driven by a historic collapse in oil prices on Monday as sweeping lockdown measures to contain the virus outbreak shut production and crush demand. London's FTSE 100 .FTSE fell 1.5% with data showing UK retail sales crashed in March, a day after surveys signalled a collapse in April business activity across the globe and U.S. jobless claims topped 26 million in five weeks
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Gilead Sciences, Inc. (NASDAQ: GILD) had its price target raised by analysts at UBS Group AG from $70.00 to $96.00. They now have a "neutral" rating on the stock.MarketBeat
- Gilead Sciences, Inc. (NASDAQ: GILD) had its price target raised by analysts at Mizuho from $90.00 to $100.00. They now have an "outperform" rating on the stock.MarketBeat
- Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at Daiwa America to a "hold" rating.MarketBeat
- GSK Drug for Rare Disease-Related Itch Meets Goal in Phase III Study [Yahoo! Finance]Yahoo! Finance
- How Gilead Is Driving Global Health Equity And Innovation [Forbes]Forbes
GILD
Earnings
- 11/6/24 - Beat
GILD
Sec Filings
- 11/20/24 - Form 8-K
- 11/15/24 - Form 424B5
- 11/13/24 - Form FWP
- GILD's page on the SEC website